Paget's disease of the breast differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 22: Line 22:


{|
{|
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="5" |Benign or Malignant
! rowspan="4" |Benign or Malignant
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! colspan="9" |Clinical manifestations
! colspan="9" |Clinical manifestations
! colspan="2" rowspan="2" |Para-clinical findings
! colspan="2" rowspan="2" |Para-clinical findings
| rowspan="5" |Gold Standard
| rowspan="4" |Gold Standard
| colspan="2" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors'''
| colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors'''
|-
|-
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="7" rowspan="2" |Symptoms
! colspan="3" rowspan="2" |Physical examination
! colspan="2" rowspan="2" |Physical examination
|-
|-
!Lab Findings
!Lab Findings
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-
|-
! colspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
!Rash
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
! rowspan="2" |Breast Exam
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Single/
Multiple
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rash
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Involved areas
!Nipple
!Nipple
DIscharge
DIscharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Erythema
!Erythema
!Single/
Multiple
!
!Involved areas
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia
!Breast Exam
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum IgE
|-
|-
! rowspan="22" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders
|
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Eczema]]
|Benign
| align="center" style="background:#F5F5F5;" |
*
| align="center" style="background:#F5F5F5;" | Scalp, face, trunk, postauricular, diaper area and axilla
|
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
**
|
| align="center" style="background:#F5F5F5;" | Nl
| align="center" style="background:#F5F5F5;" |
* Focal parakeratosis and spongiosis in epidermis
* Psoriasiform [[hyperplasia]]
* [[Neutrophils]] at the margins
| align="center" style="background:#F5F5F5;" |Risk factors include
* [[Stress]]
 
* Cold, dry weather can cause flare ups
* [[Superinfection]] with bacteria and [[candida]]
Generalized seborrheic [[erythroderma]] in immunodeficient patients
|
|
|
|-
! rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Atopic dermatitis]]
|Benign
|Benign
Line 58: Line 85:
* Epidermal barrier dysfunction
* Epidermal barrier dysfunction
* [[Immune]] dysregulation
* [[Immune]] dysregulation
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Erythema]], [[Exudate|exudates]], [[papules]],[[vesicles]], scales and crusts
*[[Erythema]], [[Exudate|exudates]], [[papules]],[[vesicles]], scales and crusts
* Infiltrated [[erythema]], [[prurigo]], scales and crusts
* Infiltrated [[erythema]], [[prurigo]], scales and crusts
|
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Young children -[[Scalp]], [[cheeks]] amd [[extensor]] surface
* Young children -[[Scalp]], [[cheeks]] amd [[extensor]] surface
* [[Adolescent|Adolescents]] -flexural areas and buttock-thigh creases
* [[Adolescent|Adolescents]] -flexural areas and buttock-thigh creases
* Adults - facial involvement and skin flexures  
* Adults - facial involvement and skin flexures  
|
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" | –
|
|
Line 103: Line 130:
* Delayed-type [[hypersensitivity]] response
* Delayed-type [[hypersensitivity]] response
* Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells
* Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]]
| align="center" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]]
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent
|
|
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" |May be multiple after 1-2 days of exposure
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
|
Line 124: Line 151:
* Contact with [[allergens]] in the past 1-2 days
* Contact with [[allergens]] in the past 1-2 days
* Positive [[family history]]
* Positive [[family history]]
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Irritant contact dermatitis]]<ref name="pmid30293200">{{cite journal |vauthors=Bains SN, Nash P, Fonacier L |title=Irritant Contact Dermatitis |journal=Clin Rev Allergy Immunol |volume= |issue= |pages= |date=October 2018 |pmid=30293200 |doi=10.1007/s12016-018-8713-0 |url=}}</ref>
|Benign
| align="center" style="background:#F5F5F5;" |
* Activation of the [[innate immune system]] by the pro-[[inflammatory]] properties of chemicals
| align="center" style="background:#F5F5F5;" |Usually single immediately after the exposure
| align="center" style="background:#F5F5F5;" | Well-demarcated red patch with a glazed surface
| align="center" style="background:#F5F5F5;" | Any area in contact with the irritant
|
| align="center" style="background:#F5F5F5;" |–
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
| align="center" style="background:#F5F5F5;" |
* [[Swelling]], [[Blister|blistering]] and scaling of the damaged area
* Dryness
* Thicker skin
| align="center" style="background:#F5F5F5;" |Nl
| align="center" style="background:#F5F5F5;" |
* Spongiosis
* Intraepidermal [[vesicles]] or bullae
* [[Necrosis]] of [[keratinocytes]]
|
| colspan="2" align="center" style="background:#F5F5F5;" |
* Cumulative exposure to [[irritants]]
* Negative hypersensitivity tests
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]]
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]]
Line 156: Line 157:
* [[Keratinocyte]] hyperproliferation
* [[Keratinocyte]] hyperproliferation
* Dysregulation of the [[immune system]]
* Dysregulation of the [[immune system]]
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales
|
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Multiple
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
* Scalp
* Scalp
Line 163: Line 167:
* Gluteal cleft
* Gluteal cleft
* Extensor surface of elbows and knees
* Extensor surface of elbows and knees
|
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|
|
Line 183: Line 184:
* Cold weather
* Cold weather
* Vitamin D deficiency  
* Vitamin D deficiency  
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Eczema|Chronic eczema]]
|Benign
| align="center" style="background:#F5F5F5;" |
*
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | Scalp, face, trunk, postauricular, diaper area and axilla
| align="center" style="background:#F5F5F5;" | +
|
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | –
| align="center" style="background:#F5F5F5;" |
**
|
| align="center" style="background:#F5F5F5;" | Nl
| align="center" style="background:#F5F5F5;" |
* Focal parakeratosis and spongiosis in epidermis
* Psoriasiform [[hyperplasia]]
* [[Neutrophils]] at the margins
| align="center" style="background:#F5F5F5;" |Risk factors include
* [[Stress]]
* Cold, dry weather can cause flare ups
* [[Superinfection]] with bacteria and [[candida]]
Generalized seborrheic [[erythroderma]] in immunodeficient patients
|
|
|-
|-
![[Melanoma|Malignant melanoma]]
![[Melanoma|Malignant melanoma]]
Line 329: Line 303:
!
!
!
!
* Distention of subareolar ducts
!
!
[[Ultrasound]]:
* Dilated milk ducts
* Fluid-filled ducts
!
!
|-
|-
Line 366: Line 345:
!
!
|-
|-
![[Mastitis]]
![[Breast abscess]]
!Benign
!Benign
!
!
Line 377: Line 356:
!+
!+
!
!
* Localized [[inflammation]] of [[breast]]
* [[Tenderness]]
!
!
!
!
!
!
!
!
[[Ultrasound]]:
* Fluid collection
!
!
|-
|-
Line 400: Line 384:
!
!
|-
|-
![[Breast abscess]]
![[Mastitis]]
!
!
* [[Benign]]
* [[Benign]]
Line 409: Line 393:
!
!
!
!
!+
!
!
!+
!
!
Line 418: Line 402:
!
!
!
!
[[Breast]] [[parenchyma]][[inflammation]]:
[[Breast]] [[parenchyma]][[inflammation]]:
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]
* [[Acute]] [[mastitis]]: [[Staphylococcus]] [[infection]]
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]][[infection]]
* [[Granulomatous]] [[mastitis]]: [[Tuberculosis]] or [[sarcoidosis]][[infection]]
!
!
[[Ultrasound]]:
* Ill-defined area with hyperechogenicity with inflamed fat lobules
* Skin thickening
|
|
|-
!Inflammatory Breast Cancer
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
|-



Revision as of 22:17, 20 February 2019

Paget's disease of the breast Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paget's disease of the breast from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Biopsy

Ultrasonography

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paget's disease of the breast differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paget's disease of the breast differential diagnosis

CDC on Paget's disease of the breast differential diagnosis

Paget's disease of the breast differential diagnosis in the news

Blogs on Paget's disease of the breast differential diagnosis

Directions to Hospitals Treating Paget's disease of the breast

Risk calculators and risk factors for Paget's disease of the breast differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]

Differential Diagnosis

Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]

Category Diseases Benign or Malignant Etiology Clinical manifestations Para-clinical findings Gold Standard Associated factors
Symptoms Physical examination
Lab Findings Histopathology
Rash Nipple

DIscharge

Erythema Single/

Multiple

Involved areas Mastalgia Breast Exam Other Serum IgE
Eczema Benign
Scalp, face, trunk, postauricular, diaper area and axilla + +
Nl Risk factors include

Generalized seborrheic erythroderma in immunodeficient patients

Skin disorders Atopic dermatitis Benign
  • Epidermal barrier dysfunction
  • Immune dysregulation
Multiple +
  • Young children -Scalp, cheeks amd extensor surface
  • Adolescents -flexural areas and buttock-thigh creases
  • Adults - facial involvement and skin flexures
  • Infra-auricular and retro-auricular fissuring
  • Nipple eczema
  • White dermographism
  • Perifollicular accentuation
  • Epidermal psoriasiform hyperplasia
  • Marked intercellular edema with spongiotic vesiculation
Allergic contact dermatitis[3] Benign Erythematous well-demarcated papules May be multiple after 1-2 days of exposure + Surrounding the area in contact with the offending agent + Nl
Psoriasis Benign Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales + Multiple +
  • Scalp
  • Trunk
  • Gluteal cleft
  • Extensor surface of elbows and knees
+ Nl Risk factors include
Malignant melanoma
Bowen’s disease
Superficial basal cell carcinoma
Pagetoid basal cell carcinoma
Benign intraductal papilloma
Pagetoid dyskeratosis
Lactiferous duct ectasia Benign
  • Distention of subareolar ducts

Ultrasound:

  • Dilated milk ducts
  • Fluid-filled ducts
Nipple duct adenoma
Benign Toker cell hyperplasia
Breast abscess Benign +

Ultrasound:

  • Fluid collection
Mondors disease
Mastitis + ±

Breast parenchymainflammation:

Ultrasound:

  • Ill-defined area with hyperechogenicity with inflamed fat lobules
  • Skin thickening
Inflammatory Breast Cancer

References

  1. 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
  2. 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
  3. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.